Axsome Therapeutics, Inc. logo

AXSMAxsome Therapeutics, Inc.

AXSM Stock Price, Valuation & Chart | Axsome Therapeutics, Inc.

Compare

AXSM Historical price chart

AXSM Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization10.44B
PE Ratio-52.96
EPS-3.83
Trading Volume656.27K
Today's High/Low205.94/200.3
Dividend Yield0.00
52 Week High/Low260.19/112.9
Shares Outstanding51.46M
AXSM Financial Statement
AXSM Analyst ratings
AXSM Analysis & performance metrics

AXSM Company profile

Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The…

AXSM Management team

Management
Darren OplandCTO
Director of Corporate Communications
Mark L. Jacobson M.A.COO
Chief Operating Officer
Ari Maizel
Chief Commercial Officer
Hunter Murdock Esq.
General Counsel & Secretary
Herriot Tabuteau M.D.CEO
Founder, Chairman, Chief Executive Officer & President
Total 5 executives

AXSM Frequently asked questions

What is Axsome Therapeutics, Inc. (AXSM) Stock Price?

Current stock price of Axsome Therapeutics, Inc. (AXSM) stock is $202.83. The stock price is +2.17% higher in the session. The intraday range can be seen from this page. Volume of Axsome Therapeutics, Inc. (AXSM) stock is 656.27K.

Last updated at 01 Sept 2026, 08:00 pm.

Why is the Axsome Therapeutics, Inc. (AXSM) stock price going up or down today?

The stock price of Axsome Therapeutics, Inc. (AXSM) can change with earnings, company news, and overall market sentiment. Axsome Therapeutics, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Axsome Therapeutics, Inc. stock expensive at its current price?

Whether Axsome Therapeutics, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for AXSM on this page is -52.96. EPS on this page is -3.83. Compare those figures with peers and growth expectations before deciding if the current Axsome Therapeutics, Inc. price is justified.

How has the stock price of Axsome Therapeutics, Inc. (AXSM) performed historically?

Historical performance for Axsome Therapeutics, Inc. (AXSM) is shown on the price chart on this page. Review multi-period moves alongside volume to see how AXSM reacted to past earnings and market events.

Should I buy Axsome Therapeutics, Inc. (AXSM) stock, at this price?

Buying Axsome Therapeutics, Inc. (AXSM) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.